Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Berberine as adjunctive therapy in schizophrenia
NCT02936414Completed
- Sponsor
- Tianjin Anding Hospital
- Start
- Jul 2014
- Primary completion
- Aug 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of berberine in schizophrenia, sponsored by Tianjin Anding Hospital. Primary endpoints: Glucose at 12 weeks and Insulin at 12 weeks. Started Jul 2014; status: completed.
02
Drugs
berberine
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT02936414.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02936414.